Following the publication of the original article [1] the authors reported that members of “Alzheimer Precision Medicine Initiative (APMI)” are not visible in the collaborator list indexed. The original article [1] has been updated. Below are members of the Alzheimer Precision Medicine Initiative Working Group (APMI–WG): Lisi Flores Aguilar, Claudio Babiloni, Filippo Baldacci, Norbert Benda, Keith L. Black, Arun L.W. Bokde, Ubaldo Bonuccelli, Karl Broich, René S. Bun, Francesco Cacciola, Juan Castrillo, Enrica Cavedo, Roberto Ceravolo, Patrizia A. Chiesa, Olivier Colliot, Cristina-Maria Coman, Jean-Christophe Corvol, Augusto Claudio Cuello, Jeffrey L. Cummings, Herman Depypere, Bruno Dubois, Andrea Duggento, Stanley Durrleman, Valentina Escott- Price, Howard Federoff, Maria Teresa Ferretti, Massimo Fiandaca, Richard A. Frank, Francesco Garaci, Remy Genthon, Nathalie George, Filippo S. Giorgi, Manuela Graziani, Marion Haberkamp, Marie-Odile Habert, Harald Hampel, Karl Herholz, Eric Karran, Seung H. Kim, Yosef Koronyo, Maya Koronyo-Hamaoui, Foudil Lamari, Todd Langevin, Stéphane Lehéricy, Simone Lista, Jean Lorenceau, Mark Mapstone, Christian Neri, Robert Nisticò, Francis Nyasse-Messene, Sid E. O’bryant, George Perry, Craig Ritchie, Katrine Rojkova, Simone Rossi, Amira Saidi, Emiliano Santarnecchi, Lon S. Schneider, Olaf Sporns, Nicola Toschi, Steven R. Verdooner, Andrea Vergallo, Nicolas Villain, Lindsay A. Welikovitch, Janet Woodcock, Erfan Younesi.

Sakr, F.a., Grothe, M.j., Cavedo, E., Jelistratova, I., Habert, M.-., Dyrba, M., et al. (2022). Correction: Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study (Alzheimer's Research & Therapy, (2019), 11, 1, (15), 10.1186/s13195-019-0466-3). ALZHEIMER'S RESEARCH & THERAPY, 14(1) [10.1186/s13195-022-01025-4].

Correction: Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study (Alzheimer's Research & Therapy, (2019), 11, 1, (15), 10.1186/s13195-019-0466-3)

Gagliardi G.;Santos A.;Duggento A.;Garaci F.;Graziani M.;Neri C.;Toschi N.;
2022-01-01

Abstract

Following the publication of the original article [1] the authors reported that members of “Alzheimer Precision Medicine Initiative (APMI)” are not visible in the collaborator list indexed. The original article [1] has been updated. Below are members of the Alzheimer Precision Medicine Initiative Working Group (APMI–WG): Lisi Flores Aguilar, Claudio Babiloni, Filippo Baldacci, Norbert Benda, Keith L. Black, Arun L.W. Bokde, Ubaldo Bonuccelli, Karl Broich, René S. Bun, Francesco Cacciola, Juan Castrillo, Enrica Cavedo, Roberto Ceravolo, Patrizia A. Chiesa, Olivier Colliot, Cristina-Maria Coman, Jean-Christophe Corvol, Augusto Claudio Cuello, Jeffrey L. Cummings, Herman Depypere, Bruno Dubois, Andrea Duggento, Stanley Durrleman, Valentina Escott- Price, Howard Federoff, Maria Teresa Ferretti, Massimo Fiandaca, Richard A. Frank, Francesco Garaci, Remy Genthon, Nathalie George, Filippo S. Giorgi, Manuela Graziani, Marion Haberkamp, Marie-Odile Habert, Harald Hampel, Karl Herholz, Eric Karran, Seung H. Kim, Yosef Koronyo, Maya Koronyo-Hamaoui, Foudil Lamari, Todd Langevin, Stéphane Lehéricy, Simone Lista, Jean Lorenceau, Mark Mapstone, Christian Neri, Robert Nisticò, Francis Nyasse-Messene, Sid E. O’bryant, George Perry, Craig Ritchie, Katrine Rojkova, Simone Rossi, Amira Saidi, Emiliano Santarnecchi, Lon S. Schneider, Olaf Sporns, Nicola Toschi, Steven R. Verdooner, Andrea Vergallo, Nicolas Villain, Lindsay A. Welikovitch, Janet Woodcock, Erfan Younesi.
2022
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore PHYS-06/A - Fisica per le scienze della vita, l'ambiente e i beni culturali
English
Con Impact Factor ISI
Sakr, F.a., Grothe, M.j., Cavedo, E., Jelistratova, I., Habert, M.-., Dyrba, M., et al. (2022). Correction: Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study (Alzheimer's Research & Therapy, (2019), 11, 1, (15), 10.1186/s13195-019-0466-3). ALZHEIMER'S RESEARCH & THERAPY, 14(1) [10.1186/s13195-022-01025-4].
Sakr, Fa; Grothe, Mj; Cavedo, E; Jelistratova, I; Habert, M-; Dyrba, M; Gonzalez-Escamilla, G; Bertin, H; Locatelli, M; Lehericy, S; Teipel, S; Dubois...espandi
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
Sakr-2022-Correction__Applicability_of_in_vivo (1).pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 679.48 kB
Formato Adobe PDF
679.48 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/404172
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact